The Novartis Global Scholars Program (NGSP) is a competitive program designed for innovators from invited institutions to gain funding for breakthrough science not covered by traditional grant support. Through this program, Novartis Biomedical Research supports projects focused on novel science with the objective of being translated to drug discovery and/or clinical research.

Curve of life world image

Resources for breakthrough science

Each Scholar will receive up to 1 mil USD funding over three years along with drug-hunting expertise from dedicated Biomedical Research scientific collaborators. In addition, a dedicated alliance manager will ensure a productive collaboration environment between Novartis and the academic institution by handling all operational facets of the NGSP.

Access to inter-disciplinary expertise

Academic scholars have access to disease biology, drug-hunting and translational research expertise. Each selected scholar will join forces with other entrepreneurially motivated Novartis Biomedical Research scientists to challenge the status quo and take bold risks for potential big rewards and will have an opportunity to advance research into early development stages.

Meet the 2023 recipients of the Novartis Global Scholars Program

With these distinguished scholars, we will focus on innovative medicines to address the worldwide burden of disease.

NGSP 2022 Scholars

NGSP 2021 Scholars

NGSP 2020 Scholars

60 world-class institutions are participating in NGSP 2023

The following institutions have been invited to participate in the 2023 NGSP. We look forward to receiving their investigators’ proposals for innovative projects that will advance our mission to improve and extend peoples’ lives.

Academic InstitutionAcademic Institution
Medical University ViennaATSeoul National University HospitalKR
University of ViennaAT Instituto de Medicina MolecularPT 
Monash UniversityAUBoston UniversityUS 
University of MelbourneAUBrigham and Women’s HospitalUS
UniQuestAUColumbia UniversityUS
WEHI (Walter & Eliza Hall Inst.)AUWeill Cornell MedicineUS
Sunnybrook Research InstituteCADuke UniversityUS
The Hospital for Sick ChildrenCAEmory UniversityUS
University of TorontoCAFred Hutchinson Cancer Research CenterUS
ETH ZurichCH Mass Eye and EarUS
University of BaselCHMassachusetts General HospitalUS
University of GenevaCHMorehouse School of MedicineUS
Geneva University HospitalsCHNorthwestern UniversityUS
University of ZurichCHOhio State UniversityUS
LMU MunichDERutgers, The State University of New JerseyUS
University Hospital MunichDESchepens Eye Research Institute
of Mass Eye and Ear
Institut PasteurFRTemple UniversityUS
Francis Crick InstituteGBTufts UniversityUS
Imperial College LondonGBUniversity of California, Los AngelesUS
University of BirminghamGBUniversity of California, BerkeleyUS
University of Cambridge GBUniversity of California, San DiegoUS
University of OxfordGBUniversity of North Carolina at Chapel HillUS
Council of Scientific & Industrial Research -
Centre for Cellular and Molecular Biology (CSIR-CCMB)
INUniversity of ArizonaUS
Tel Aviv UniversityISUniversity of ChicagoUS
Weizmann Institute of ScienceISUniversity of Massachusetts Chan Medical SchoolUS
Kyoto UniversityJPUniversity of MichiganUS
Okinawa Institute of Science and TechnologyJPUniversity of PittsburghUS
Osaka UniversityJPVanderbilt UniversityUS
University of TokyoJPWashington University in St. LouisUS
Asan Medical CenterKRYale UniversityUS